Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of HESTER BIOSCIENCES. For more details, see the HESTER BIOSCIENCES quarterly results and HESTER BIOSCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 1.8 |
No. of shares | m | 8.51 |
1 Week | % | 4.0 |
1 Month | % | 20.7 |
1 Year | % | -4.6 |
52 week H/L | Rs | 1,928.5/1,292.9 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
HESTER BIOSCIENCES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 1,825 | 2,044 | 2,278 | 3,180 | 2,852 | |
Low | Rs | 1,040 | 870 | 934 | 1,887 | 1,416 | |
Sales per share (Unadj.) | Rs | 209.2 | 215.4 | 251.9 | 276.2 | 312.7 | |
Earnings per share (Unadj.) | Rs | 47.8 | 36.4 | 40.8 | 46.4 | 32.9 | |
Diluted earnings per share | Rs | 47.8 | 36.4 | 40.8 | 46.4 | 33.0 | |
Cash flow per share (Unadj.) | Rs | 61.6 | 51.8 | 56.4 | 65.9 | 57.3 | |
Dividends per share (Unadj.) | Rs | 11.00 | 6.60 | 10.00 | 10.00 | 8.00 | |
Adj. dividends per share | Rs | 11.00 | 6.60 | 10.00 | 10.00 | 8.00 | |
Avg Dividend yield | % | 0.8 | 0.5 | 0.6 | 0.4 | 0.4 | |
Book value per share (Unadj.) | Rs | 208.5 | 236.3 | 268.3 | 305.5 | 328.7 | |
Adj. book value per share | Rs | 208.6 | 236.4 | 268.4 | 305.6 | 328.8 | |
Shares outstanding (eoy) | m | 8.51 | 8.51 | 8.51 | 8.51 | 8.51 | |
Price / Sales ratio | x | 6.8 | 6.8 | 6.4 | 9.2 | 6.8 | |
Avg P/E ratio | x | 29.9 | 40.0 | 39.4 | 54.6 | 64.7 | |
P/CF ratio (eoy) | x | 23.2 | 28.1 | 28.5 | 38.4 | 37.3 | |
Price / Book Value ratio | x | 6.9 | 6.2 | 6.0 | 8.3 | 6.5 | |
Dividend payout | % | 23.0 | 18.1 | 24.5 | 21.5 | 24.3 | |
Avg Mkt Cap | Rs m | 12,186 | 12,396 | 13,661 | 21,552 | 18,152 | |
Total wages/salary | Rs m | 289 | 407 | 389 | 453 | 560 |
HESTER BIOSCIENCES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,781 | 1,833 | 2,143 | 2,350 | 2,661 | |
Other income | Rs m | 72 | 64 | 47 | 137 | 154 | |
Total revenues | Rs m | 1,853 | 1,896 | 2,190 | 2,487 | 2,814 | |
Gross profit | Rs m | 680 | 554 | 653 | 604 | 548 | |
Depreciation | Rs m | 118 | 131 | 133 | 166 | 207 | |
Interest | Rs m | 66 | 74 | 66 | 41 | 93 | |
Profit before tax | Rs m | 569 | 413 | 501 | 535 | 402 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 162 | 103 | 154 | 140 | 121 | |
Profit after tax | Rs m | 407 | 310 | 347 | 395 | 280 | |
Gross profit margin | % | 38.2 | 30.2 | 30.5 | 25.7 | 20.6 | |
Effective tax rate | % | 28.4 | 25.0 | 30.7 | 26.2 | 30.2 | |
Net profit margin | % | 22.9 | 16.9 | 16.2 | 16.8 | 10.5 |
HESTER BIOSCIENCES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,417 | 1,593 | 1,615 | 1,948 | 2,276 | |
Current liabilities | Rs m | 487 | 835 | 614 | 969 | 1,487 | |
Net working cap to sales | % | 52.2 | 41.4 | 46.7 | 41.6 | 29.7 | |
Current ratio | x | 2.9 | 1.9 | 2.6 | 2.0 | 1.5 | |
Inventory Days | Days | 12 | 21 | 13 | 75 | 47 | |
Debtors Days | Days | 67,366,745 | 116 | 84 | 86 | 109 | |
Net fixed assets | Rs m | 1,578 | 2,273 | 2,495 | 3,674 | 4,424 | |
Share capital | Rs m | 85 | 85 | 85 | 85 | 85 | |
"Free" reserves | Rs m | 1,690 | 1,926 | 2,198 | 2,515 | 2,712 | |
Net worth | Rs m | 1,775 | 2,011 | 2,283 | 2,600 | 2,797 | |
Long term debt | Rs m | 584 | 765 | 828 | 1,645 | 1,849 | |
Total assets | Rs m | 2,995 | 3,866 | 4,110 | 5,622 | 6,700 | |
Interest coverage | x | 9.6 | 6.6 | 8.6 | 14.2 | 5.3 | |
Debt to equity ratio | x | 0.3 | 0.4 | 0.4 | 0.6 | 0.7 | |
Sales to assets ratio | x | 0.6 | 0.5 | 0.5 | 0.4 | 0.4 | |
Return on assets | % | 15.8 | 9.9 | 10.0 | 7.7 | 5.6 | |
Return on equity | % | 22.9 | 15.4 | 15.2 | 15.2 | 10.0 | |
Return on capital | % | 26.9 | 17.5 | 18.2 | 13.6 | 10.6 | |
Exports to sales | % | 6.7 | 11.0 | 16.6 | 9.8 | 11.6 | |
Imports to sales | % | 2.5 | 0.6 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 120 | 202 | 357 | 230 | 309 | |
Imports (cif) | Rs m | 45 | 12 | 0 | 0 | 0 | |
Fx inflow | Rs m | 128 | 366 | 357 | 230 | 309 | |
Fx outflow | Rs m | 74 | 42 | 21 | 137 | 39 | |
Net fx | Rs m | 54 | 324 | 336 | 93 | 270 |
HESTER BIOSCIENCES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 467 | 368 | 581 | 87 | 236 | |
From Investments | Rs m | -217 | -745 | -384 | -1,166 | -770 | |
From Financial Activity | Rs m | 27 | 187 | -182 | 1,115 | 418 | |
Net Cashflow | Rs m | 283 | -171 | -23 | 35 | -116 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Bhupendra V Gandhi | COMP SEC: Vinod Mali | YEAR OF INC: 1987 | BSE CODE: 524669 | FV (Rs): 10 | DIV YIELD (%): 0.5 |
Read: HESTER BIOSCIENCES 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare HESTER BIOSCIENCES With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.